Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CFG vs GSK✓SelectedUSD · GSKCFG vs GSK performance historyLatest closeAs of-1.60%11/18
Stock and ETF performance explorer

CFG vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+26.6%
GSK return
+7.0%
Excess return
+19.6%
Maximum drawdown
-18.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.6%-1.3%-0.3%-1.2%
7D-5.1%-3.1%-2.0%-4.3%
30D-0.4%-0.9%+0.5%-0.2%
3M-14.9%-4.2%-10.7%-14.0%
6M+2.9%-1.6%+4.5%+3.0%
YTD+9.3%+2.6%+6.7%+6.8%
1Y+26.6%+6.2%+20.4%+21.7%
All+26.6%+7.0%+19.6%+21.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling